Prevalence of latent tuberculosis before biotherapy initiation in rheumatoid arthritis and spondyloarthritis: data from the Moroccan biotherapy registryLamia Oulkadi, R. Bahiri, H. Hassikou et al.|Rheumatology International|2021Cited by 9
The first biological choice in patients with rheumatoid arthritis: data from the Moroccan register of biotherapies.Meryem Eddaoudi, R. Bahiri, S. Rostom et al.|PubMed|2021Cited by 6
Therapeutic Maintenance Level of Methotrexate in Rheumatoid Arthritis: A RBSMR StudyLamia Oulkadi, R. Bahiri, S. Rostom et al.|Mediterranean Journal of Rheumatology|2022Cited by 5
Utilisation des AINS et des antalgiques chez les patients ayant une spondyloarthrite sous biothérapie. Données du registre de biothérapie de la Société Marocaine de rhumatologie (RBSMR)Anass Kherrab, R. Niamane, Hanane Chitachen et al.|Revue du Rhumatisme|2020Cited by 2
Tuberculosis Under Biotherapy in Patients with Spondyloarthritis: Data from the Moroccan Biotherapy Registry (RBSMR) during 3 Years of Follow UpS. Zemrani, R. Bahiri, Bouchra Amine et al.|Mediterranean Journal of Rheumatology|2025Cited by 1